Clinical Trial: A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older with Retinitis Pigmentosa

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06891885) titled 'A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older with Retinitis Pigmentosa' on Feb. 27.

Brief Summary: The Goal of this study is to evaluate the safety, tolerability, and clinical responses following single dose of DSP-3077. Study enrolls both male and female patients in 3 cohorts with each cohort defined by visual acuity (VA) criteria and dose level of DSP-3077. Each cohort will include 4 participants.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Retinitis Pigmentosa

Intervention: DRUG: DSP-3077 Retinal Sheet Cohort 1

Fo...